Epoetin-Alfa Erythropoietin Market Outlook 2034: Valued at US$12.92B with 4.60% CAGR
The global epoetin-alfa erythropoietin market is witnessing steady expansion driven by rising chronic disease prevalence and the growing demand for anemia management therapies worldwide. Epoetin-alfa, a recombinant erythropoietin, is widely used to stimulate red blood cell production in patients suffering … Read more